Dr. Reddy's Laboratories Buy Sell Tips Discussion
The Dr. Reddy’s Laboratories Limited along with its subsidiaries is one of the leading operating companies as the pharmaceutical brand. Founded in the year 1984, the company is evolving as a global pharmaceutical company. The main products of the labs include finished dosage forms, active pharmaceutical ingredients and intermediates, and biotechnology products. Researches are also conducted in the major field like cancer treatment, diabetes analysis, cardiovascular issues, and inflammation as well as on bacterial infections. The company’s main attention is focused around therapeutic categories of cardiovascular, diabetes management, gastro-intestinal, and pain management.
In the year 1970, the Indira Gandhi led Government of India, proposed various laws mainly for the international pharmaceutical patents. The idea behind, was to reduce the healthcare cost mainly for the people lying in BPL region. This law however did a drastic help to the country’s pharmaceutical sector. Till 1990, the company became a global giant and right now, it is doing business of buying and selling the pharmaceutical products in United States, Russian Federation, parts of United Kingdom and Europe and of course in India. More recently, the company got into a commercial agreement with Rheoscience A/S mainly for the development of Balaglitazone/DRF 2593, which is a partial PPAR-gamma agonist for the treatment of type2 diabetes. Also agreement with ClinTec is done by Dr.Reddy’s Lab for cancer treatment and recently had another agreement with Argenta Discovery Ltd for chronic obstructive pulmonary disease treatment. The annual reports suggest that the total current asset of the company is around $1761 million USD.
As per the current status, Dr.Reddy’s Labs, is a trusted company both in terms of product delivery and investment market. If you are planning to buy stocks in this pharmaceutical giant then you can find expert analysis or tips from this platform. Looking at its present market strength, it is better to invest money in its stocks keeping in view long term planning.
Like Our posts? Subscribe to free stock market tips Email subscription
Related posts:
Buy Dr Reddy with a target of Rs 1200 and stop loss of Rs 1070, says Rakesh Bansal, technical analyst, on CNBC Awaaz. The stock is currently trading at Rs 1145, up 1.89% on the BSE.
Buy Dr Reddy with a target of Rs 1250 and stop loss of Rs 1130, says Neera Jain, technical analyst, on CNBC Awaaz. The stock is currently trading at Rs 1177, up 2.9% on the BSE.
Hold Dr Reddy’s with target of Rs 1233 and stop loss of Rs 1080, says a market expert on Zee Business. The stock is currently trading at Rs 1100, down 4.6% on the BSE.
Buy Dr Reddy’s and hold for 6 months to one year, says Anu Jain, technical analyst, on CNBC Awaaz. The stock is currently trading at Rs 1109, up 0.4% on the BSE.
Buy Dr Reddy on dips with a long-term target of Rs 1480 and stop loss of Rs 1203, says Anu Jain, technical analyst, on CNBC TV18. The stock is currently trading at Rs 1255, up 1.92% on the BSE.
Buy Dr Reddy’s with target of Rs 1240-1250 and stop loss of Rs 1180, says Sudarshan Sukhani, technical analyst, on CNBC TV18. The stock is currently trading at Rs 1225.25, up 1% on the BSE.
Buy Dr Reddy’s at Rs 1220-1230 with target of Rs 1300 and stop loss of Rs 1200, says Rajesh Jain of SMC Global Securities on Zee Business. The stock is currently trading at Rs 1248, up 1.1% on the BSE.
Buy Dr Reddy’s at Rs 1308 with target of Rs 1328 and stop loss of Rs 1298, says Hemen Kapadia, technical analyst, on CNBC TV18.
Hold Dr Reddy’s with targets of Rs 1350 and 1375 on crossing its resistance of Rs 1325, says Mileen Vasudeo, technical analyst, on NDTV Profit. Keep trailing stop loss of Rs 1270, he adds. The stock is currently trading at Rs 1305.85, up 1% on the BSE.
Buy Dr Reddy’s with target of Rs 1350 and stop loss of Rs 1270, says JK Jain of Karvy Stock Broking on Zee Business. The stock is currently trading at Rs 1309, down 0.5% on the BSE.
Buy Dr Reddy’s with target of Rs 1450 and stop loss of Rs 1380, says Mitesh Thacker, technical analyst, on CNBC TV18. The stock is currently trading at Rs 1409, up 0.4% on the BSE.
Buy Dr Reddy’s with stop loss of Rs 1380, says Pradeep Surekha, technical analyst, on Zee Business. The stock is currently trading at Rs 1487, up 1.4% on the BSE.
Buy Dr Reddy’s with target of Rs 1510 and stop loss of Rs 1434, says D Prasad, market analyst, on Zee Business. The stock is currently trading at Rs 1489.40, up 1.6% on the BSE.
Book profits in Dr Reddy’s on every rally, says Jagdish Thakkar of Fortune Fiscal on Zee Business. The stock is currently trading at Rs 1434.05, up 0.8% on the BSE.
Buy Dr Reddy’s with target of Rs 1500 and stop loss of Rs 1455, says Sudarshan Sukhani, technical analyst, on CNBC TV18. The stock is currently trading at Rs 1470.10, up 0.7% on the BSE.
Hold Dr Reddy’s with stop loss of 1310, says Pankaj Jain of Satguru Capital on Zee Business. It will show an upmove soon, he adds. The stock is currently trading at Rs 1350.95, up 0.03% on the BSE.